P2B-138

State Health Centre Oncology Department (Budapest, Hungary) › P2B-138

P2B-138

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Phase II
State Health Centre Oncology Department (Budapest, Hungary) · Dr. Clarke
consented 2013-07-24

completed

AEs

2

Serious

0

Dropout signal

–

Adverse events

2

Grade 3 mucosal inflammation with onset in cycle 3 (2013-09-26); assessed as related to study drug (probable); resolved 2013-10-03; action: drug interrupted.

severe assessed

Grade 2 alopecia with onset in cycle 1 (2013-08-24); assessed as related to study drug (probable); not resolved at last follow-up.

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.